Skip to content
10-Q

Quarterly Report

Pharma-Bio Serv, Inc. PBSV

0001654954-24-011967

← back to feed
Filed
Sep 16, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Sep 10, 2024 22.96M sh
Current Liabilities Q3 2024 · Jul 31, 2024 $1.9M
Current Liabilities Q3 2024 · Oct 31, 2023 $2.15M
Total Liabilities Q3 2024 · Jul 31, 2024 $2.63M
Total Liabilities Q3 2024 · Oct 31, 2023 $3.78M
Current Assets Q3 2024 · Jul 31, 2024 $15.94M
Current Assets Q3 2024 · Oct 31, 2023 $19.4M
Total Assets Q3 2024 · Jul 31, 2024 $16.32M
Total Assets Q3 2024 · Oct 31, 2023 $19.9M
Dividends Paid Q3 2024 · Dec 15, 2023 $1.72M
Dividends Paid Q3 2024 · Jul 31, 2023 $0
Dividends Paid Q3 2024 · Jul 31, 2023 $1.72M
Shares Diluted Q3 2024 · Jul 31, 2023 22.98M sh
Shares Diluted Q3 2024 · Jul 31, 2023 22.99M sh
Stock Repurchased Q3 2024 · Jul 31, 2023 $5.08K
Stock Repurchased Q3 2024 · Jul 31, 2023 $33.55K
Capex Q3 2024 · Jul 31, 2023 $0
Capex Q3 2024 · Jul 31, 2023 $8.83K
Operating Cash Flow Q3 2024 · Jul 31, 2023 $956.77K
Operating Cash Flow Q3 2024 · Jul 31, 2023 $1.58M
Stockholders Equity Q3 2024 · Jul 31, 2023 $16.19M
Stockholders Equity Q3 2024 · Apr 30, 2023 $15.67M
Stockholders Equity Q3 2024 · Oct 31, 2022 $16.56M
Sga Expense Q3 2024 · Jul 31, 2023 $1.09M
Sga Expense Q3 2024 · Jul 31, 2023 $2.97M
Net Income Q3 2024 · Jul 31, 2023 $526.24K
Net Income Q3 2024 · Jul 31, 2023 $1.36M
Operating Income Q3 2024 · Jul 31, 2023 $460.47K
Operating Income Q3 2024 · Jul 31, 2023 $1.17M
Gross Profit Q3 2024 · Jul 31, 2023 $1.55M
Gross Profit Q3 2024 · Jul 31, 2023 $4.14M
Cost Of Revenue Q3 2024 · Jul 31, 2023 $3.03M
Cost Of Revenue Q3 2024 · Jul 31, 2023 $9.24M
Revenue Q3 2024 · Jul 31, 2023 $4.58M
Revenue Q3 2024 · Jul 31, 2023 $13.38M